Evidence map›Paper›PMID 36189411›Full record

ArticleHealth science reports2022

Color vision devices for color vision deficiency patients: A systematic review and meta-analysis.

Shiva Ram Male, Bindiganavale R Shamanna, Rishi Bhardwaj, Chakravarthy Bhagvati, Baskar Theagarayan

Abstract read
In one paragraph

Article in Health science reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Impact of ChromaGen lenses on colour vision test performance of individuals with congenital colour vision deficiency.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shiva Ram MaleSchool of Medical Sciences University of Hyderabad Gachibowli India.ORCID 0000-0001-5872-4990
Bindiganavale R ShamannaSchool of Medical Sciences University of Hyderabad Gachibowli India.ORCID https://orcid.org/0000-0001-9270-837X
Rishi BhardwajSchool of Medical Sciences University of Hyderabad Gachibowli India.
Chakravarthy BhagvatiSchool of Computer and Information Sciences University of Hyderabad Gachibowli India.
Baskar TheagarayanDepartment of Optometry and Vision Sciences, Centre for Vision across the Life Span, School of Applied Sciences University of Huddersfield Huddersfield UK.ORCID 0000-0002-5788-3735

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: There is insufficient evidence to support that using electronic or optical color vision devices improve color perception with current advanced technology. The purpose of this study is to compare and analyze the different color vision devices available for patients with color vision deficiency (CVD) and evaluate whether these devices improved their color perception. Methods: This review included randomized, experimental, comparative studies, as well as narrative reviews, prototype and innovation studies, and translational studies, followed by case-control and clinical trials with nonsurgical interventions studies, that is, electronic color vision devices, optical devices, and contact lens-based studies, with standardized inclusion and exclusion criteria. Results: The primary outcome studied was the performance of color vision devices, both objective and subjective. Secondary outcomes included the ease of use and accessibility of color vision devices and technology. The grading of recommendation, assessment, development, and evaluation framework was used to develop a systematic approach for consideration and clinical practice recommendation for CVD devices for color-deficient populations. We incorporated meta-analysis reports from a total of Conclusion: This review concludes that commercially available color vision devices, such as EnChroma Glasses, Chromagen filters, and EnChroma Cx-14 do not provide clinically significant evidence that subjective color perception has improved. As a result, recommending these color vision devices to the CVD population may not prove high beneficial/be counterproductive. However, only a few color shades can be perceived differently. This systematic review and analysis will aid future research and development in color vision devices.

Indexed as

color perceptioncolor visioncolor vision deficiencycolor vision devicesmeta‐analysissystematic review

Identifiers

PMID36189411
PMCPMC9498227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.